1. Home
  2. PODD vs TRMB Comparison

PODD vs TRMB Comparison

Compare PODD & TRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • TRMB
  • Stock Information
  • Founded
  • PODD 2000
  • TRMB 1978
  • Country
  • PODD United States
  • TRMB United States
  • Employees
  • PODD N/A
  • TRMB 12700
  • Industry
  • PODD Medical/Dental Instruments
  • TRMB Industrial Machinery/Components
  • Sector
  • PODD Health Care
  • TRMB Industrials
  • Exchange
  • PODD Nasdaq
  • TRMB Nasdaq
  • Market Cap
  • PODD 16.5B
  • TRMB 17.8B
  • IPO Year
  • PODD 2007
  • TRMB 1990
  • Fundamental
  • Price
  • PODD $261.71
  • TRMB $72.36
  • Analyst Decision
  • PODD Buy
  • TRMB Buy
  • Analyst Count
  • PODD 16
  • TRMB 7
  • Target Price
  • PODD $265.81
  • TRMB $82.29
  • AVG Volume (30 Days)
  • PODD 528.9K
  • TRMB 1.3M
  • Earning Date
  • PODD 11-07-2024
  • TRMB 02-10-2025
  • Dividend Yield
  • PODD N/A
  • TRMB N/A
  • EPS Growth
  • PODD 235.68
  • TRMB 342.93
  • EPS
  • PODD 5.74
  • TRMB 5.97
  • Revenue
  • PODD $1,983,900,000.00
  • TRMB $3,632,300,000.00
  • Revenue This Year
  • PODD $23.56
  • TRMB N/A
  • Revenue Next Year
  • PODD $18.07
  • TRMB N/A
  • P/E Ratio
  • PODD $45.91
  • TRMB $12.21
  • Revenue Growth
  • PODD 27.42
  • TRMB N/A
  • 52 Week Low
  • PODD $160.19
  • TRMB $48.60
  • 52 Week High
  • PODD $279.77
  • TRMB $76.97
  • Technical
  • Relative Strength Index (RSI)
  • PODD 46.07
  • TRMB 53.98
  • Support Level
  • PODD $258.96
  • TRMB $72.53
  • Resistance Level
  • PODD $279.77
  • TRMB $74.98
  • Average True Range (ATR)
  • PODD 6.52
  • TRMB 1.51
  • MACD
  • PODD -1.90
  • TRMB -0.52
  • Stochastic Oscillator
  • PODD 4.61
  • TRMB 10.00

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About TRMB Trimble Inc.

Trimble Inc provides a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has four reportable segments: Buildings and Infrastructure, Geospatial, Resources and Utilities, and Transportation. The company generates the majority of its revenue from the Buildings and Infrastructure segment, which primarily serves customers working in architecture, engineering, construction, design, asset management, operations, and maintenance.

Share on Social Networks: